SOAT1 and systemic lupus erythematosus: Studies show that JAK/STAT inhibitors could be effectively used to treat multiple diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), indicating that JAK/STAT serves a vital role in disease development (161, 162).